1. Home
  2. EZGO vs ENTO Comparison

EZGO vs ENTO Comparison

Compare EZGO & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZGO
  • ENTO
  • Stock Information
  • Founded
  • EZGO 2014
  • ENTO 2014
  • Country
  • EZGO China
  • ENTO United States
  • Employees
  • EZGO N/A
  • ENTO N/A
  • Industry
  • EZGO Motor Vehicles
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZGO Consumer Discretionary
  • ENTO Health Care
  • Exchange
  • EZGO Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • EZGO 2.0M
  • ENTO 2.3M
  • IPO Year
  • EZGO 2021
  • ENTO 2016
  • Fundamental
  • Price
  • EZGO $0.32
  • ENTO $0.39
  • Analyst Decision
  • EZGO
  • ENTO
  • Analyst Count
  • EZGO 0
  • ENTO 0
  • Target Price
  • EZGO N/A
  • ENTO N/A
  • AVG Volume (30 Days)
  • EZGO 112.1K
  • ENTO 553.4K
  • Earning Date
  • EZGO 01-17-2025
  • ENTO 05-15-2025
  • Dividend Yield
  • EZGO N/A
  • ENTO N/A
  • EPS Growth
  • EZGO N/A
  • ENTO N/A
  • EPS
  • EZGO N/A
  • ENTO N/A
  • Revenue
  • EZGO $20,895,830.00
  • ENTO N/A
  • Revenue This Year
  • EZGO N/A
  • ENTO N/A
  • Revenue Next Year
  • EZGO N/A
  • ENTO N/A
  • P/E Ratio
  • EZGO N/A
  • ENTO N/A
  • Revenue Growth
  • EZGO 18.98
  • ENTO N/A
  • 52 Week Low
  • EZGO $0.29
  • ENTO $0.19
  • 52 Week High
  • EZGO $1.91
  • ENTO $1.27
  • Technical
  • Relative Strength Index (RSI)
  • EZGO 41.86
  • ENTO 40.04
  • Support Level
  • EZGO $0.30
  • ENTO $0.36
  • Resistance Level
  • EZGO $0.35
  • ENTO $0.52
  • Average True Range (ATR)
  • EZGO 0.02
  • ENTO 0.07
  • MACD
  • EZGO -0.00
  • ENTO -0.02
  • Stochastic Oscillator
  • EZGO 31.88
  • ENTO 8.97

About EZGO EZGO Technologies Ltd.

EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: